PTC Therapeutics Inc. buy Wells Fargo & Company
Start price
08.12.23
/
50%
€24.20
Target price
08.12.24
€34.41
Performance (%)
19.83%
Price
02.08.24
€29.00
Summary
This prediction is currently active. The prediction currently has a performance of 19.83%. This prediction currently runs until 08.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | -4.605% | -4.605% |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
Comments by Wells_Fargo___Compan for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $37.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat